Literature DB >> 7769175

Abnormal somatosensory evoked potentials in patients with classic galactosemia: correlation with neurologic outcome.

F R Kaufman1, E J Horton, P Gott, J A Wolff, M D Nelson, C Azen, F R Manis.   

Abstract

In classic galactosemia, long-term neurologic sequelae can include low cognitive functioning and a curious neurologic syndrome with tremors, dysmetria, and ataxia. An abnormal white-matter signal on cerebral magnetic resonance imaging (MRI) is present in almost all patients; some have mild cerebral or cerebellar atrophy and focal white-matter lesions. The present study was undertaken to assess the integrity of myelinated pathways by recording somatosensory evoked potentials. Results were correlated with age at diagnosis, severity of illness, age at evoked potentials, neurologic examination, MRI studies and cognitive outcome as measured by the Woodcock-Johnson Revised Standard Cognitive Battery. Evoked potentials were abnormal in 17 (28%) of 60 patients who had median nerve, and 26 (77%) of 34 patients who had posterior tibial nerve studies. Abnormalities of the central rather than the peripheral nervous system were most common. Evoked potentials correlated with severity of presenting symptoms (P = .011), age at evoked potential testing (P = .029), and presence of focal white-matter lesions on MRI (P = .049). Results of neurophysiologic testing showed no correlation with the Woodcock-Johnson Battery. Patients with classic galactosemia may have abnormal conduction along myelinated pathways that is associated with other central deficits. Myelin, which contains galactose, may be adversely affected in this inborn error of metabolism.

Entities:  

Mesh:

Year:  1995        PMID: 7769175     DOI: 10.1177/088307389501000109

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

1.  [Central myelination disorder in classical galactosemia : Case report of two sisters].

Authors:  C D Reimers; S Hähnel; C Terborg
Journal:  Nervenarzt       Date:  2017-02       Impact factor: 1.214

Review 2.  Galactose toxicity in animals.

Authors:  Kent Lai; Louis J Elsas; Klaas J Wierenga
Journal:  IUBMB Life       Date:  2009-11       Impact factor: 3.885

3.  FDG-PET findings in patients with galactosaemia.

Authors:  J G Dubroff; C Ficicioglu; S Segal; N A Wintering; A Alavi; A B Newberg
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.